The fund is an actively managed exchange-traded fund (“ETF”) that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase. Show more

Location: | Industry: | Sector:


Market Cap

0.00

52 Wk Range

$28.93 - $36.44

Previous Close

$35.98

Open

$35.98

Volume

18,563

Day Range

$35.86 - $35.98

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2

Initiation

BI-1910 + KEYTRUDA Details
Solid tumor/s, Cancer

Phase 2a

Data readout

BI-1206 +/- rituximab & acalabrutinib Details
Non-Hodgkin lymphoma

Susp. Mover™

Phase 2a

Data readout

BI-1808 +/- KEYTRUDA Details
T-cell lymphoma

Susp. Mover™

Phase 2a

Data readout

BT-001 + KEYTRUDA Details
Cancer, Solid tumor/s

Phase 1/2

Update

BI-1607 Details
Solid tumor/s, Cancer

Phase 1

Data readout

Phase 1

Data readout